Tasnin Al Hasib

Mr. Tasnin Al Hasib

Student - Bachelor of Biochemistryand Molecular Biology
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
SPShamrat Kumar Paul
Shamrat Kumar Paul
MSMd. Saddam
Md. Saddam
AMAfsana Mimi
Afsana Mimi
Bonglee KimBonglee Kim
Bonglee Kim
CCNs are a specific type of matricellular protein, which are essential signaling molecules, and play multiple roles in multicellular eukaryotes. This family of proteins consists of six separate members, which exist only in vertebrates. The architecture of CCN proteins is multi-modular comprising four distinct modules. CCN Proteins achieve their primary functional activities by binding with several integrin7 receptors. The CCN family has been linked to cell adhesion, chemotaxis and migration, mitogenesis, cell survival, angiogenesis, differentiation, tumorigenesis, chondrogenesis, and wound healing, among other biological interactions. Breast cancer is the most commonly diagnosed cancer worldwide and CCN regulated breast cancer stands at the top. A favorable or unfavorable association between various CCNs has been reported in patients with breast carcinomas. The pro-tumorigenic CCN1, CCN2, CCN3, and CCN4 may lead to human breast cancer, although the anti-tumorigenic actions of CCN5 and CCN6 are also present. Several studies have been conducted on CCN proteins and cancer in recent years. CCN1 and CCN3 have been shown to exhibit a dual nature of tumor inhibition and tumor suppression to some extent in quiet recent time. Pharmacological advances in treating breast cancer by targeting CCN proteins are also reported. In our study, we intend to provide an overview of these research works while keeping breast cancer in focus. This information may facilitate early diagnosis, early prognosis and the development of new therapeutic strategies.

28 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SSSeung-Hee Seo
Seung-Hee Seo
SPShamrat Kumar Paul
Shamrat Kumar Paul
MSMita Shikder
Mita Shikder
MKMushira Khanam
Mushira Khanam
Popy GhoshPopy Ghosh
Popy Ghosh
YKYoungjoo Kwon
Youngjoo Kwon
Glial cells comprise the non-sensory parts of the central nervous system as well as the peripheral nervous system. Glial cells, also known as neuroglia, constitute a significant portion of the mammalian nervous system and can be viewed simply as a matrix of neural cells. Despite being the “Nervenkitt” or “glue of the nerves”, they aptly serve multiple roles, including neuron repair, myelin sheath formation, and cerebrospinal fluid circulation. Ependymal cells are one of four kinds of glial cells that exert distinct functions. Tumorigenesis of a glial cell is termed a glioma, and in the case of an ependymal cell, it is called an ependymoma. Among the various gliomas, an ependymoma in children is one of the more challenging brain tumors to cure. Children are afflicted more severely by ependymal tumors than adults. It has appeared from several surveys that ependymoma comprises approximately six to ten percent of all tumors in children. Presently, the surgical removal of the tumor is considered a standard treatment for ependymomas. It has been conspicuously evident that a combination of irradiation therapy and surgery is much more efficacious in treating ependymomas. The main purpose of this review is to present the importance of both a deep understanding and ongoing research into histopathological features and prognoses of ependymomas to ensure that effective diagnostic methods and treatments can be developed.

1 January 2020 in Journal of Advanced Biotechnology and Experimental Therapeutics
Verified
Journal Article
Closed access
MD. Hasanur RahmanMD. Hasanur Rahman
MD. Hasanur Rahman
Md. Sarwar ZahanMd. Sarwar Zahan
Md. Sarwar Zahan
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
MKMushira Khanam
Mushira Khanam
Md Jamal UddinMd Jamal Uddin
Md Jamal Uddin
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is cause of a global pandemic which is demolishing global health and economy. SARS-CoV-2 infected patients are hospitalized with pneumonia where almost 20-30% of patients are led to kidney failure. The entry of SARS-CoV-2 into the systemic circulation leads to acute kidney injury (AKI) which may develop chronic kidney disease (CKD). In addition, patients who are diagnosed with AKI or CKD are at major risk of SARS-CoV-2 infection. Although a significant number of compounds have been proposed and the existing drugs have also been tested for repurposing, no specific therapy has been approved yet. SARS-CoV-2 invades human cells binding to the receptor of angiotensin-converting enzyme 2 (ACE2) via the receptor-binding domain. Cells that express ACE2 are susceptible to SARS-CoV-2 infection and the proportion of ACE2-positive cells in kidney proximal tubule is approximately 4%, indicating that SARS-CoV-2 might damage the kidney tubules leading to fatal kidney injury. Therefore, a better understanding of the potential mechanisms involved in SARS-CoV-2 infection-mediated kidney disease may unveil a novel therapeutic strategy against kidney diseases during COVID-19.

11 November 2021 in Applied Microbiology: Theory & Technology
Verified
Journal Article
Closed access
PDF file
MSMita Shikder
Mita Shikder
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
PRPranta Ray
Pranta Ray
AKAbul Bashar Ripon Khalipha
Abul Bashar Ripon Khalipha
LKLutful Kabir
Lutful Kabir
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) is a causative agent of the potentially fatal coronavirus disease (COVID-19). Coronavirus targets the human respiratory system primarily. It can also infect the gastrointestinal, hepatic, and central nervous systems of humans, avians, bats, livestock, mice, and many other wild animals, as these are primary targets of the pathogen. This study aims to screen out the most potent inhibitor for SARS-CoV-2 (COVID-19) spike glycoproteins among the selected drugs, and computational tools have been utilized for this purpose. The selected drugs have been designed to explore their structural properties in this study by molecular orbital calculation. To inhibit the spike glycoproteins, the performance of these drugs was also examined by molecular docking calculation. In improving the performance of drugs, non-bond interactions play a significant role. To determine the chemical reactivity of all the medicines, HOMO and LUMO energy values were also calculated. The combined calculations exhibited that Ledipasvir among the selected drugs can be the most potent drug to treat SARS-CoV-2 compared to other medications.

20 November 2019
Verified
Book Chapter
Closed access
PDF file
SPShamrat Kumar Paul
Shamrat Kumar Paul
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
PRPranta Ray
Pranta Ray
LKLutful Kabir
Lutful Kabir
AKAbul Bashar Ripon Khalipha
Abul Bashar Ripon Khalipha
Tuberculosis (TB) is one of the most known ancient human disease which is caused by Mycobacterium Tuberculosis (MTB). Surprisingly, at present it is one of the major causes of death of human around the globe. Complete genome sequencing of MTB provides us a storehouse of genomic information to study about MTB’s complex pathogenicity. Among 3924 Open Reading frame of MTB, the Uncharacterized Protein Rv1708 is encoded by Rv1708 gene and it is a inferred to be a cell cycle regulatory protein. It is anticipated that during cell division the Uncharacterized Protein Rv1708 play a critical role in septum formation of MTB. Thus, it becomes the mediator of cell cycle progression and cell division. Inhibition of bacterial cell division by blocking its associated protein is known to be therapeutic target for defeating disease. But the Uncharacterized Protein Rv1708 of the MTB remained unexplored. So, our aim is to propose the structural and functional features in addition to reveal the physicochemical properties. Homology modelling of the Uncharacterized Protein Rv1708 was generated by using Phyre2 and Swiss Model. The in-stability index generated by using the ExPasy’s ProtParam tool shows that the Uncharacterized Protein Rv1708 is stable and its nature is acidic. Ramachandran map analysis by MolProbity reveals 95.5% of all residues were in allowed regions and 87.7% of all residues were in favored regions; which is indicating strong evidence of good quality of protein structure. This in-silico process will unveil the role of unexplored Uncharacterized Protein Rv1708 of MTB, and so it can pave the way for enriching our knowledge of the pathogenesis and drug-targeting approach for MTB.

28 January 2021 in Preprints.org
Verified
Preprint
Open access
Abu Saim Mohammad SaikatAbu Saim Mohammad Saikat
Abu Saim Mohammad Saikat
Kazi Ahsan AhmedKazi Ahsan Ahmed
Kazi Ahsan Ahmed
SASaddam
Saddam
AMAfsana Mimi
Afsana Mimi
Tasnin Al HasibTasnin Al Hasib
Tasnin Al Hasib
Md Ataur RahmanMd Ataur Rahman
Md Ataur Rahman
CCNs are specific type of matricellular proteins, which are essential signaling molecules, and play multiple roles in multicellular eukaryotes. This family of proteins consists of six separate members in mammals. The architecture of CCN proteins is multimodular and comprises four distinct motifs. CCN proteins achieve their specific physiological functions by binding to integrin receptors. The CCN family has been implicated in both cure and disease with impacts on biological interactions, such as cell adhesion, chemotaxis and migration, mitogenesis, cell survival, angiogenesis, differentiation, tumorigenesis, immune functions, chondrogenesis, and wound healing. Breast cancer is the most commonly diagnosed cancer worldwide and the leading cause of cancer mortality among women triggered by atypical expression of CCNs. A favorable or unfavorable association between various CCNs has been reported in patients with breast carcinomas. Aberrant expression of CCN1 intensifies the proliferation of epithelial cells that line the lobes and ducts of the breast. Evidence also shows that the expression of CCN2 can ameliorate tumor growth and metastasis. However, CCN3 (NOV), CCN5 (WISP-2), and CCN6 (WISP-3) are consistent with neoplastic development and metastasis repression. Particular CCN members can develop tumors and cancer progression, whereas others can competitively counter the processes. Several studies have been conducted on CCN proteins and cancer in recent years. In our study, we intend to provide an overview of those research works while keeping breast carcinoma on focus. We believe that the importance of the CCN protein family in breast cancer should be reconsidered.